Dr Malinda Itchins is a thoracic medical oncologista doctor who specialises in the study, diagnosis and treatment of cancer and clinician researcher at Chris O’Brien Lifehouse, and Royal North Shore, Sydney. She is a senior clinical lecturer with the University of Sydney. Malinda is a Board Director and the Lung Cancera disease where abnormal cells split without control and spread to other nearby body tissue and/or organs Chair with the Clinical Oncologythe study, diagnosis and treatment of cancer Society of Australia (COSA), and Advancedat a late stage, far along NSCLC Co-Chair on the Thoracic Oncology Group of Australasia (TOGA) Scientific Committee. She is Primary Investigator on several lung cancer clinical trialsresearch studies performed to test new treatments, tests or procedures and evaluate their effectiveness on various diseases and her research focus to date has been in patterns of care, the real-world experience, biomarker exploration and drug resistance in lung cancer.
In 2020 she graduated from her doctoral studies investigating drug resistance in ALK-rearranged non-small cell lung cancer both preclinically, and via a clinical trial. Malinda is the Lung Cancer Chair for the Clinical Oncology of Australia (COSA) Council, and Early Career Representative for the Thoracic Oncology Group of Australasia (TOGA) Scientific Committee. She is a Primary and Sub Investigator on a number of lung cancer clinical trials. Her research focus to date has been in patterns of care, the real-world experience and drug resistance in oncogene driven lung cancers and optimising the multidisciplinary care pathway and clinical predictors of survival in pancreatic cancer.
She is passionate about the evolution of precision medicine and equity of access to care in thoracic cancers.
Location
119-143 Missenden Road, Camperdown NSW, Australia
